bioRxiv Science⌕ Search

Biology subjects

Hartmannsberger, B.

Publications and source records attributed to Hartmannsberger, B..

2 recordsLinked to original sources

Sex differences define the molecular and cellular phenotypes of pain resolution in dorsal root ganglia

The dorsal root ganglion (DRG), a key site for the initiation and maintenance of neuropathic pain, was examined for sex-dependent phenotypes in sensory neurons, satellite glial cells (SGCs), and local macrophages following traumatic nerve injury and during natural pain resolution. Systematic analysis of 7,495 DRG immunofluorescence images and 62 transcriptomes revealed pronounced sex-specific, multicellular DRG phenotypes, especially during pain resolution. System parameters, including tissue size and neuron density also showed sex-dependent differences. Neuropathic pain resolved without tissue or sensory neuron loss. After injury, macrophages invaded the space between sensory neurons and satellite glial cells (SGCs); this was partially reversed during pain resolution, particularly in males. In females, immune-related gene expression and macrophage phenotypes persisted longer, while SGC activation and contact to sensory neurons was more persistent in males. During resolution, synaptic and excitability-related processes were pronounced in both sexes. However, while injury responses were largely shared between sexes, the resolution phase displayed distinctly sex-specific molecular and cellular signatures. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=197 SRC="FIGDIR/small/691610v1_ufig1.gif" ALT="Figure 1"> View larger version (76K): org.highwire.dtl.DTLVardef@4063c7org.highwire.dtl.DTLVardef@156c0d2org.highwire.dtl.DTLVardef@8d4be4org.highwire.dtl.DTLVardef@7182bd_HPS_FORMAT_FIGEXP M_FIG C_FIG In briefAnalysis of [~]7,500 bioimages and 62 transcriptomes reveals pronounced sex differences in rat dorsal root ganglia during pain resolution after peripheral nerve injury. HighlightsO_LIIn both female and male rats, peripheral nerve injury and subsequent pain resolution occur in the dorsal root ganglia (DRG) without neuronal or tissue loss. C_LIO_LISex influences DRG tissue size, neuron density, immune and glial phenotypes, and molecular-cellular responses to nerve injury and pain resolution. C_LIO_LIFollowing injury, macrophages infiltrate the space between sensory neurons and satellite glial cells (SGCs); this process reverses during pain resolution, particularly in males. C_LIO_LIIn females, immune phenotypes remain more stable throughout pain resolution, while SGC contact is reduced. C_LIO_LIPain resolution involves not only the reversal of injury-induced cell changes but also the activation of resolution-specific gene programs related to synaptic signaling, neuronal excitation, and cell-cell communication. C_LIO_LISex differences on the molecular-cellular level are less prevalent after nerve injury but become prominent during pain resolution. C_LI

neuroscience↗

TAM receptors mediate the Fpr2-driven pain resolution and fibrinolysis after nerve injury

Nerve injury causes neuropathic pain and multilevel nerve barrier disruption. Nerve barriers consist of perineurial, endothelial, and myelin barriers. So far, it is unclear whether resealing nerve barriers fosters pain resolution and recovery. To this end, we analysed the nerve barrier property portfolio, pain behaviour battery, and lipidomics for precursors of specialized pro-resolving meditators (SPMs) and their receptors in chronic constriction injury of rat sciatic nerve to identify targets for pain resolution by resealing the selected nerve barriers. Of the three nerve barriers - perineurium, capillaries, and myelin - only capillary tightness specifically against larger molecules, such as fibrinogen, recuperated with pain resolution. Fibrinogen immunoreactivity was not only elevated in rats at the time of neuropathic pain but also in nerve biopsies from patients with (but not without) painful polyneuropathy indicating that sealing of the vascular barrier might be novel approach in pain treatment. 15R-HETE (hydroxyeicosatetraenoic acid), a precursor of aspirin-triggered lipoxin A4, were specifically upregulated at the beginning of pain resolution. Repeated local application of resolvin D1-laden nanoparticles or Fpr2 agonists sex-independently resulted in accelerated pain resolution and fibrinogen removal. Clearing macrophages (Cd206) and fibrinolytic pathways (Plat) were also induced while inflammation (Tnf) and inflammasomes (Nlrp3) were unaffected by this treatment. Blocking TAM receptors (Tyro3, Axl, and Mer) and tyrosine kinase receptors linking haemostasis and inflammation completely inhibited all the effects. In summary, nanoparticles can be used as transporters for fleeting lipids, such as SPMs, and therefore expand the array of possible therapeutic agents. Thus, the Fpr2-Cd206-TAM receptor axis may be a suitable target for strengthening the capillary barrier, removing endoneurial fibrinogen, and boosting pain resolution in patients with chronic neuropathic pain.

neuroscience↗